drugset / Trial / NCT04522297

Nor-epinephrine Versus Midodrine/Octreotide in Patients With Hepatorenal Syndrome

NCT04522297

RandomizedParallel-groupOpen-labelTreatment

Summary

Hepatorenal syndrome is a functional renal impairment occurring in cirrhotic patients . It develops secondary to splanchnic arterial vasodilatation which decreases the effective blood volume, activate the renin-angiotensin-aldosterone system, and stimulate of sympathetic nervous system.This study aims to compare the efficacy of nor-epinephrine versus midodrine/ octreotide, together with intravenous albumin on renal functions of patients with hepatorenal acute kidney injury.

Timeline

Start
2018-04-15
Primary completion
2020-01-23
Completion
2020-01-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Midodrine Small molecule Oral
Comparator Norepinephrine Other / unclassified Intravenous
Subject Octreotide Peptide Subcutaneous

Indications